CHRISTIANA CARE HEALTH SYSTEM
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $9.2M
- Transactions
- 3,002
- Companies
- 40
- Average per transaction
- $3,074
Who reported the payments
| Merck | $1,158,064 |
| Angiodynamics, Inc. | $1,093,636 |
| Novartis | $860,631 |
| New York Blood Center, Inc. | $637,638 |
| Kls-martin L.p. | $603,444 |
| Karyopharm Therapeutics Inc. | $359,516 |
| Pfizer | $317,872 |
| AbbVie | $313,415 |
| AstraZeneca | $295,920 |
| Boston Scientific | $290,262 |
| Amgen | $263,723 |
| Incyte Corporation | $256,851 |
| TG Therapeutics, Inc. | $217,956 |
| Genentech, Inc. | $215,236 |
| Eli Lilly | $173,350 |
| Acerta Pharma LLC | $154,392 |
| Penumbra, Inc. | $152,662 |
| Mimedx Group, Inc. | $129,800 |
| Siemens Medical Solutions USA, Inc. | $124,874 |
| Chiesi USA, Inc. | $123,951 |
| Boehringer Ingelheim | $117,300 |
| Linde Gas & Equipment Inc. | $88,416 |
| CSL Behring | $87,819 |
| Janssen Research & Development, LLC | $83,623 |
| Amneal Pharmaceuticals LLC | $80,231 |
| Inari Medical, Inc. | $78,360 |
| Stryker | $73,027 |
| Genmab U.S., Inc. | $51,249 |
| E.r. Squibb & Sons, L.L.C. | $48,150 |
| Johnson & Johnson | $46,984 |
| Abbott | $45,963 |
| Takeda Pharmaceuticals U.S.A., Inc. | $43,908 |
| Roche Products Limited | $37,200 |
| F. Hoffmann-la Roche AG | $36,995 |
| Astrazeneca UK Limited | $34,704 |
| Pharmacyclics LLC, An Abbvie Company | $32,639 |
| Dompe Farmaceutici S.p.a. | $32,008 |
| Array Biopharma Inc | $29,471 |
| Amarin Pharma, Inc. | $23,994 |
| National Marrow Donor Program | $22,010 |